GSE192710 ZIC2 ZNF423 inhibition stem cell 4 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE192710_ZIC2_ZNF423 inhibition_stem cell_4_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE192710_ZIC2_ZNF423 inhibition_stem cell_4_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE192710_ZIC2_ZNF423 inhibition_stem cell_4_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE192710_ZIC2_ZNF423 inhibition_stem cell_4_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

maternally expressed 3

Gene

family with sequence similarity 106 member A

Gene

cutA divalent cation tolerance like, pseudogene

Gene

deleted in lymphocytic leukemia 2

Gene

small nucleolar RNA host gene 33

Gene

zinc finger protein 271, pseudogene

Gene

RASSF8 antisense RNA 1

Gene

SOX21 antisense RNA 1

Gene

MIR9-2 host gene

Gene

XG Y-linked 2 (pseudogene)

  • Gene

    maternally expressed 3


  • Gene

    family with sequence similarity 106 member A


  • Gene

    cutA divalent cation tolerance like, pseudogene


  • Gene

    deleted in lymphocytic leukemia 2


  • Gene

    small nucleolar RNA host gene 33


  • Gene

    zinc finger protein 271, pseudogene


  • Gene

    RASSF8 antisense RNA 1


  • Gene

    SOX21 antisense RNA 1



  • Gene

    XG Y-linked 2 (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.